Bone and mineral disorder in renal transplant patients: overview of pathology, clinical, and therapeutic aspects

P Molinari, CM Alfieri, D Mattinzoli, M Campise… - Frontiers in …, 2022 - frontiersin.org
Renal transplantation (RTx) allows us to obtain the resolution of the uremic status but is not
frequently able to solve all the metabolic complications present during end-stage renal …

[HTML][HTML] Mineral and bone disorder after kidney transplantation

PT Taweesedt, S Disthabanchong - World journal of transplantation, 2015 - ncbi.nlm.nih.gov
After successful kidney transplantation, accumulated waste products and electrolytes are
excreted and regulatory hormones return to normal levels. Despite the improvement in …

Natural history of serum calcium and parathyroid hormone following renal transplantation

Z Al-Moasseb, E Aitken - Transplantation Proceedings, 2016 - Elsevier
Background Hyperparathyroidism is common in end-stage renal disease. It often persists
following renal transplantation (RTx) and remains elusive to manage due to the lack of …

Phosphocalcic markers and calcification propensity for assessment of interstitial fibrosis and vascular lesions in kidney allograft recipients

L Berchtold, B Ponte, S Moll, K Hadaya, O Seyde… - PloS one, 2016 - journals.plos.org
Renal interstitial fibrosis and arterial lesions predict loss of function in chronic kidney
disease. Noninvasive estimation of interstitial fibrosis and vascular lesions is currently not …

Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients

S Prakobsuk, S Sirilak, K Vipattawat… - Clinical and …, 2017 - Springer
Background After kidney transplantation, fibroblast growth factor-23 (FGF-23) normally
returns to baseline within 1 year whereas hyperparathyroidism persists in most kidney …

Calcium and phosphate levels after kidney transplantation and long-term patient and allograft survival

J Chevarria, DJ Sexton, SL Murray… - Clinical Kidney …, 2021 - academic.oup.com
Background Non-traditional cardiovascular risk factors, including calcium and phosphate
derangement, may play a role in mortality in renal transplant. The data regarding this effect …

Распространенность и факторы риска гиперпаратиреоза у пациентов после трансплантации почки: опыт одного центра

ОН Ветчинникова, МЮ Иванова - Вестник трансплантологии и …, 2020 - journal.transpl.ru
Аннотация Цель исследования. Оценить распространенность гиперпаратиреоза (ГПТ)
и факторы, влияющие на его развитие, у пациентов, перенесших трансплантацию …

[PDF][PDF] Hypercalcemia After Kidney Transplantation: A Single-Center Experience

M Gücün, GŞ Manga - Hypertension, 2022 - jag.journalagent.com
Objective: To examine the causes of hypercalcemia developing after kidney transplantation
and investigate its effects on graft functions. Methods: The results of 104 patients were …

Трансплантация почки и гиперпаратиреоз

ОН Ветчинникова - Трансплантология, 2017 - cyberleninka.ru
Успешная трансплантация почки нивелирует эндокринно-метаболические нарушения,
предрасполагающие к формированию закономерного для хронической болезни почек …

Современные подходы к коррекции минеральных и костных нарушений у реципиентов почечного трансплантата

ОН Ветчинникова - Вестник трансплантологии и …, 2018 - journal.transpl.ru
Аннотация Синдром минерально-костных нарушений у пациентов с хронической
болезнью почек, перенесших трансплантацию почки, включает гипофосфатемию …